Altimmune, Inc.ALTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+26.4%
5Y CAGR-12.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+26.4%/yr
Annual compound
5Y CAGR
-12.5%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$5.71M-29.6%
2024$8.11M+8.4%
2023$7.48M+164.4%
2022$2.83M+1708.0%
2021$-176000.00-101.6%
2020$11.17M+1160.4%
2019$886304.00+135.6%
2018$-2.49M-13336.4%
2017$-18506.00-481.5%
2016$4851.00-